Recent studies indicate that a low Hb level is an unfavorable prognostic factor in diverse cancer types, including non-small cell lung cancer (NSCLC), ovarian carcinoma and pancreatic cancer [12]–[14]. Here, GSTM1 is linked to non-small cell lung carcinoma.